Cite
HARVARD Citation
Rynn, C. et al. (2022). A translational strategy employing physiologically based modelling to predict the pharmacological active dose of RO7119929, an oral prodrug of a targeted cancer immunotherapy TLR7 agonist. Xenobiotica. pp. 855-867. [Online].